
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| PLP(L) | 199 | 35.4% | -0.80 | 114 | 34.4% |
| SCL(L) | 93 | 16.5% | 0.53 | 134 | 40.5% |
| LH(L) | 180 | 32.0% | -3.32 | 18 | 5.4% |
| ICL(L) | 40 | 7.1% | 0.66 | 63 | 19.0% |
| CentralBrain-unspecified | 25 | 4.4% | -inf | 0 | 0.0% |
| CA(L) | 20 | 3.6% | -3.32 | 2 | 0.6% |
| SLP(L) | 5 | 0.9% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns LHPV8c1 | % In | CV |
|---|---|---|---|---|---|
| CL127 (L) | 2 | GABA | 39 | 7.3% | 0.3 |
| LoVP2 (L) | 10 | Glu | 36 | 6.7% | 0.6 |
| VP1m+_lvPN (L) | 2 | Glu | 34 | 6.4% | 0.1 |
| LHPV6k1 (L) | 3 | Glu | 27 | 5.1% | 0.1 |
| aMe23 (L) | 1 | Glu | 22 | 4.1% | 0.0 |
| CL362 (L) | 1 | ACh | 17 | 3.2% | 0.0 |
| PLP180 (L) | 3 | Glu | 15 | 2.8% | 0.5 |
| LHAV3o1 (L) | 3 | ACh | 12 | 2.2% | 0.4 |
| LHAV4i1 (L) | 2 | GABA | 11 | 2.1% | 0.5 |
| PLP182 (L) | 2 | Glu | 9 | 1.7% | 0.1 |
| LHPV2a1_d (L) | 2 | GABA | 8 | 1.5% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 7 | 1.3% | 0.0 |
| CB2904 (L) | 2 | Glu | 7 | 1.3% | 0.7 |
| LHPV4c1_c (L) | 3 | Glu | 7 | 1.3% | 0.4 |
| M_ilPNm90 (R) | 1 | ACh | 6 | 1.1% | 0.0 |
| PLP085 (L) | 1 | GABA | 6 | 1.1% | 0.0 |
| SLP447 (L) | 1 | Glu | 6 | 1.1% | 0.0 |
| LHAV5a8 (L) | 2 | ACh | 6 | 1.1% | 0.7 |
| VP2+_adPN (L) | 1 | ACh | 5 | 0.9% | 0.0 |
| LHAD2d1 (L) | 1 | Glu | 5 | 0.9% | 0.0 |
| LHPV4j2 (L) | 1 | Glu | 5 | 0.9% | 0.0 |
| VP1d_il2PN (R) | 1 | ACh | 5 | 0.9% | 0.0 |
| M_l2PNl23 (L) | 1 | ACh | 5 | 0.9% | 0.0 |
| VP2_adPN (L) | 1 | ACh | 5 | 0.9% | 0.0 |
| LHPV5b3 (L) | 2 | ACh | 5 | 0.9% | 0.2 |
| LHAV6a7 (L) | 2 | ACh | 5 | 0.9% | 0.2 |
| CL283_b (L) | 2 | Glu | 5 | 0.9% | 0.2 |
| DA2_lPN (L) | 3 | ACh | 5 | 0.9% | 0.6 |
| PVLP102 (L) | 1 | GABA | 4 | 0.7% | 0.0 |
| DN1a (L) | 1 | Glu | 4 | 0.7% | 0.0 |
| LHPV4b3 (L) | 1 | Glu | 4 | 0.7% | 0.0 |
| PVLP109 (L) | 1 | ACh | 4 | 0.7% | 0.0 |
| CB2786 (L) | 1 | Glu | 4 | 0.7% | 0.0 |
| PVLP109 (R) | 1 | ACh | 4 | 0.7% | 0.0 |
| LHPV2a1_e (L) | 1 | GABA | 4 | 0.7% | 0.0 |
| VP1d_il2PN (L) | 1 | ACh | 4 | 0.7% | 0.0 |
| VM1_lPN (L) | 1 | ACh | 4 | 0.7% | 0.0 |
| VM6_adPN (L) | 1 | ACh | 4 | 0.7% | 0.0 |
| LHPV5b2 (L) | 2 | ACh | 4 | 0.7% | 0.5 |
| VP1m+VP2_lvPN2 (L) | 2 | ACh | 4 | 0.7% | 0.5 |
| LHPV2a1_c (L) | 3 | GABA | 4 | 0.7% | 0.4 |
| SLP003 (L) | 1 | GABA | 3 | 0.6% | 0.0 |
| LoVP40 (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| LHPV4b5 (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| CB4056 (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| PLP084 (L) | 1 | GABA | 3 | 0.6% | 0.0 |
| PVLP003 (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| PLP181 (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| WED168 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| VLP_TBD1 (R) | 1 | ACh | 3 | 0.6% | 0.0 |
| LHPV6o1 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| M_ilPNm90 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| SMP495_a (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| LHAV2d1 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| SLP004 (L) | 1 | GABA | 3 | 0.6% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 3 | 0.6% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 3 | 0.6% | 0.0 |
| mALD1 (R) | 1 | GABA | 3 | 0.6% | 0.0 |
| SMP091 (L) | 2 | GABA | 3 | 0.6% | 0.3 |
| CL004 (L) | 2 | Glu | 3 | 0.6% | 0.3 |
| CL015_b (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| LHAV3e2 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| CL032 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| VLP_TBD1 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| SLP069 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| SLP456 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| SLP337 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| LHPV2b3 (L) | 1 | GABA | 2 | 0.4% | 0.0 |
| SLP002 (L) | 1 | GABA | 2 | 0.4% | 0.0 |
| LHPV6h2 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LHAV5a9_a (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| CL315 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| CL294 (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| CL026 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| LHAV3e1 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LHCENT13_b (L) | 1 | GABA | 2 | 0.4% | 0.0 |
| aMe20 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| SLP457 (L) | 1 | unc | 2 | 0.4% | 0.0 |
| LoVP45 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| MeVP52 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| PPL201 (L) | 1 | DA | 2 | 0.4% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 2 | 0.4% | 0.0 |
| SLP313 (L) | 2 | Glu | 2 | 0.4% | 0.0 |
| M_l2PNm16 (L) | 2 | ACh | 2 | 0.4% | 0.0 |
| CL246 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| CB1976 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP214 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LoVP50 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVP106 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV2i1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV3q1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL126 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB1503 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHCENT2 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| SMP142 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| LHPV4i4 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LC29 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB1510 (R) | 1 | unc | 1 | 0.2% | 0.0 |
| LHAD2e3 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV2c1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHCENT13_d (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| CL090_b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP185 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP395 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| M_lPNm13 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV4c1_a (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| PLP115_b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL064 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHPV2a2 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHPV2a3 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHAV2g3 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV2e1_a (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHPV6k2 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB2733 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP334 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CL141 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| M_adPNm3 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL152 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LoVP98 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB3908 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL253 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| CB0670 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CL073 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| M_l2PNm17 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV3p1 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| DA4l_adPN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LT75 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PPM1201 (L) | 1 | DA | 1 | 0.2% | 0.0 |
| LHCENT5 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LoVCLo2 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| LHAV2n1 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHCENT8 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHCENT4 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LT66 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 1 | 0.2% | 0.0 |
| downstream partner | # | NT | conns LHPV8c1 | % Out | CV |
|---|---|---|---|---|---|
| SMP315 (L) | 3 | ACh | 52 | 7.6% | 0.5 |
| SMP495_a (L) | 1 | Glu | 35 | 5.1% | 0.0 |
| SMP317 (L) | 4 | ACh | 33 | 4.8% | 0.7 |
| KCg-d (L) | 2 | DA | 30 | 4.4% | 0.2 |
| SLP269 (L) | 1 | ACh | 27 | 4.0% | 0.0 |
| SLP137 (L) | 2 | Glu | 16 | 2.3% | 0.2 |
| SMP279_b (L) | 2 | Glu | 16 | 2.3% | 0.0 |
| CL175 (L) | 1 | Glu | 15 | 2.2% | 0.0 |
| SMP314 (L) | 2 | ACh | 15 | 2.2% | 0.1 |
| AVLP091 (L) | 1 | GABA | 14 | 2.1% | 0.0 |
| CL126 (L) | 1 | Glu | 14 | 2.1% | 0.0 |
| SMP494 (L) | 1 | Glu | 14 | 2.1% | 0.0 |
| CB1803 (L) | 2 | ACh | 14 | 2.1% | 0.6 |
| LHAV2d1 (L) | 1 | ACh | 13 | 1.9% | 0.0 |
| SMP321_a (L) | 1 | ACh | 12 | 1.8% | 0.0 |
| LoVP45 (L) | 1 | Glu | 12 | 1.8% | 0.0 |
| CL032 (L) | 1 | Glu | 10 | 1.5% | 0.0 |
| SMP321_b (L) | 1 | ACh | 10 | 1.5% | 0.0 |
| SMP278 (L) | 1 | Glu | 10 | 1.5% | 0.0 |
| LHPV12a1 (L) | 1 | GABA | 10 | 1.5% | 0.0 |
| LHPV6p1 (L) | 1 | Glu | 9 | 1.3% | 0.0 |
| SMP423 (L) | 1 | ACh | 9 | 1.3% | 0.0 |
| PLP169 (L) | 1 | ACh | 9 | 1.3% | 0.0 |
| LHPD3c1 (L) | 1 | Glu | 8 | 1.2% | 0.0 |
| SLP360_a (L) | 1 | ACh | 8 | 1.2% | 0.0 |
| LHPV4j2 (L) | 1 | Glu | 8 | 1.2% | 0.0 |
| SLP382 (L) | 1 | Glu | 8 | 1.2% | 0.0 |
| SMP580 (L) | 1 | ACh | 8 | 1.2% | 0.0 |
| SMP255 (L) | 1 | ACh | 8 | 1.2% | 0.0 |
| KCg-m (L) | 2 | DA | 8 | 1.2% | 0.5 |
| SMP323 (L) | 3 | ACh | 8 | 1.2% | 0.4 |
| SLP381 (L) | 1 | Glu | 7 | 1.0% | 0.0 |
| PLP155 (L) | 1 | ACh | 7 | 1.0% | 0.0 |
| IB059_a (L) | 1 | Glu | 7 | 1.0% | 0.0 |
| SLP334 (L) | 2 | Glu | 7 | 1.0% | 0.4 |
| CL272_b1 (L) | 1 | ACh | 6 | 0.9% | 0.0 |
| LHPV2a1_a (L) | 1 | GABA | 6 | 0.9% | 0.0 |
| LHAV3e1 (L) | 1 | ACh | 6 | 0.9% | 0.0 |
| SLP447 (L) | 1 | Glu | 6 | 0.9% | 0.0 |
| SMP330 (L) | 1 | ACh | 5 | 0.7% | 0.0 |
| CL272_b2 (L) | 1 | ACh | 5 | 0.7% | 0.0 |
| SLP119 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| SLP120 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| PLP258 (L) | 1 | Glu | 4 | 0.6% | 0.0 |
| LHPV2a1_d (L) | 1 | GABA | 4 | 0.6% | 0.0 |
| SLP361 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| CL153 (L) | 1 | Glu | 4 | 0.6% | 0.0 |
| SLP118 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| SMP421 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| SMP422 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| CL026 (L) | 1 | Glu | 4 | 0.6% | 0.0 |
| SMP326 (L) | 2 | ACh | 4 | 0.6% | 0.5 |
| CL271 (L) | 2 | ACh | 4 | 0.6% | 0.5 |
| CL348 (R) | 2 | Glu | 4 | 0.6% | 0.5 |
| CB2459 (R) | 1 | Glu | 3 | 0.4% | 0.0 |
| SLP467 (L) | 1 | ACh | 3 | 0.4% | 0.0 |
| SMP319 (L) | 1 | ACh | 3 | 0.4% | 0.0 |
| SLP136 (L) | 1 | Glu | 3 | 0.4% | 0.0 |
| CL282 (L) | 1 | Glu | 3 | 0.4% | 0.0 |
| SMP531 (L) | 1 | Glu | 3 | 0.4% | 0.0 |
| CL200 (L) | 1 | ACh | 3 | 0.4% | 0.0 |
| SLP206 (L) | 1 | GABA | 3 | 0.4% | 0.0 |
| CB1326 (L) | 2 | ACh | 3 | 0.4% | 0.3 |
| CL246 (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| PLP067 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| CL364 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| SLP456 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| SMP328_c (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| PLP180 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| SLP079 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| CB3361 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| CL129 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| SMP329 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| LHPV4b3 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| LHPV7a2 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| LHPV6k1 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| LHPV2a5 (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| CB2027 (R) | 1 | Glu | 2 | 0.3% | 0.0 |
| SMP312 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| CL099 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| CB2600 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| LHPV4a7 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| CL021 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| SLP305 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| LHCENT13_b (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| LHPV10c1 (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| LHPV6g1 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| CL283_b (L) | 2 | Glu | 2 | 0.3% | 0.0 |
| LHPV2b5 (L) | 2 | GABA | 2 | 0.3% | 0.0 |
| SMP252 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHAV4i1 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LHAV3e2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL255 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP472 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP528 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV5b2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP414 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP277 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CL272_b3 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP185 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP007 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP8 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP395 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPD2b1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV2a2 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LC37 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP341_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP404 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHAV4g17 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LHPV2a1_e (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CB0510 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB0645 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PS185 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP457 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| LHCENT3 (L) | 1 | GABA | 1 | 0.1% | 0.0 |